Literature DB >> 31416744

Effectiveness of a mindfulness-based psychoeducation group programme for early-stage schizophrenia: An 18-month randomised controlled trial.

Wai Tong Chien1, Ho Yu Cheng2, Terry W McMaster3, Annie L K Yip4, JoJo C L Wong2.   

Abstract

Current psychosocial interventions in schizophrenia are evidenced to improve patients' illness-related knowledge, mental status and relapse rate, but substantive benefits to patients, such as their functioning and insight into the illness, remain uncertain. This multi-centre randomised clinical trial aimed to examine the effects of mindfulness-based psycho-education group intervention for adult patients with early-stage schizophrenia over an 18-month follow-up. The controlled trial was conducted with a repeated-measure, three-arm design at two psychiatric outpatient clinics in Jilin (China) and Hong Kong. A stratified random sample of 180 outpatients with schizophrenia spectrum disorders (60/group) was randomly assigned to a mindfulness-based psycho-education group programme, psycho-education group and treatment-as-usual group. The primary outcomes on patients' psychosocial functioning and other patient outcomes, such as psychotic symptoms, in the three groups were compared over the 18-month follow-up (baseline and 1-week, 9-month and 18-month post-intervention). One hundred and sixty (89%) patients completed at least two post-tests. Their mean age and duration of illness were 25-28 years (SD = 6.1-7.8) and 2.1-2.5 years (SD = 1.3-2.0; range 4-54 months), respectively. Compared with the two other groups, the mindfulness-based group exhibited a significantly greater improvement with moderate to large effect sizes (Cohen's d = 0.49-0.98) in functioning (p = 0.005), duration of psychiatric re-hospitalisations (p = 0.007), psychotic symptoms (p = 0.008) and illness insight (p = 0.001) over the 18-month follow-up. Supplementary MRI findings indicated that the mindfulness-based intervention resulted in significant changes in gray matter volume and density in brain regions concerning attention and emotional regulation. Mindfulness-oriented psycho-education group intervention can be an effective intervention for adults with early-stage schizophrenia and exert long-term effects on patients' functioning and mental conditions.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Functioning; Mindfulness-based intervention; Psycho-education group; Psychotic symptoms; Schizophrenia

Mesh:

Year:  2019        PMID: 31416744     DOI: 10.1016/j.schres.2019.07.053

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  Global research on cognitive behavioural therapy for schizophrenia from 2000 to 2019: a bibliometric analysis via CiteSpace.

Authors:  Xinxing Fei; Shiqi Wang; Xiaojiao Zheng; Kezhi Liu; Xuemei Liang
Journal:  Gen Psychiatr       Date:  2021-01-28

2.  Home practice in mindfulness-based interventions for psychosis groups: a systematic review and qualitative study.

Authors:  Pamela Jacobsen; Twinkle Choksi; Katherine Sawyer; Cassia Maximen; Emma Harding; Matthew Richardson
Journal:  BMC Psychol       Date:  2022-01-12

3.  Mindfulness on Daily Life Coping in People Experiencing Psychosis: A Randomized Controlled Trial.

Authors:  Emilio López-Navarro; Susana Al-Halabí
Journal:  Int J Clin Health Psychol       Date:  2022-02-23

4.  Mindfulness-based interventions for non-affective psychosis: a comprehensive systematic review and meta-analysis.

Authors:  Annie Lai King Yip; Thanos Karatzias; Wai Tong Chien
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

5.  Rationale, Methods, Feasibility, and Preliminary Outcomes of a Transdiagnostic Prevention Program for At-Risk College Students.

Authors:  Anne S Burke; Benjamin G Shapero; Andrea Pelletier-Baldelli; Wisteria Y Deng; Maren B Nyer; Logan Leathem; Leah Namey; Carrie Landa; Corinne Cather; Daphne J Holt
Journal:  Front Psychiatry       Date:  2020-02-25       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.